Canada markets closed

Emmaus Life Sciences, Inc. (EMMA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.10000.0000 (0.00%)
At close: 12:53PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
15,480
18,390
20,610
23,167
Cost of Revenue
3,944
2,588
3,312
2,248
Gross Profit
11,536
15,802
17,298
20,919
Operating Expenses
Research Development
2,274
1,725
4,110
2,408
Selling General and Administrative
19,395
20,663
19,316
18,543
Total Operating Expenses
21,669
22,388
23,426
20,951
Operating Income or Loss
-10,133
-6,586
-6,128
-32
Interest Expense
4,255
5,013
3,101
5,989
Total Other Income/Expenses Net
-4,006
354
-7,453
6,193
Income Before Tax
-17,676
-10,565
-15,921
973
Income Tax Expense
11
60
25
-381
Income from Continuing Operations
-17,687
-10,625
-15,946
1,354
Net Income
-17,687
-10,625
-15,946
1,354
Net Income available to common shareholders
-17,687
-10,625
-15,946
1,354
Basic EPS
-0.08
-0.21
-0.32
0.03
Diluted EPS
-0.08
-0.21
-0.32
0.03
Basic Average Shares
51,703
49,440
49,253
48,897
Diluted Average Shares
51,703
49,440
49,253
48,897